Management of localized prostate cancer: the pendulum swings (back to the middle)

by Winston Vuong, Oliver Sartor, Sumanta K Pal
Published 2014-08-01

Radium-223 in metastatic castration resistant prostate cancer

by Winston Vuong, Oliver Sartor, Sumanta K Pal
Published 2014-06-01

CYP17 inhibitors in prostate cancer: latest evidence and clinical potential

by Anitha B. Alex, Sumanta K. Pal, Neeraj Agarwal
Published 2016-07-01

The role of peroxisome proliferator-activated receptor gamma in prostate cancer

by Catherine Elix, Sumanta K Pal, Jeremy O Jones
Published 2018-01-01

Disease-specific survival in de novo metastatic renal cell carcinoma in the cytokine and targeted therapy era.

by Sumanta K Pal, Rebecca A Nelson, Nicholas Vogelzang
Published 2013-01-01

Renal cell carcinoma: An update for the practicing urologist

by Sumanta K. Pal, Paulo Bergerot, Robert A. Figlin
Published 2015-01-01

Tivozanib in renal cell carcinoma: a new approach to previously treated disease

by Nicholas J. Salgia, Zeynep B. Zengin, Sumanta K. Pal
Published 2020-05-01

Factors that influence the androgen receptor cistrome in benign and malignant prostate cells

by Ben T. Copeland, Juan Du, Sumanta K. Pal, Jeremy O. Jones
Published 2019-12-01

Wnt/β-Catenin Signaling and Immunotherapy Resistance: Lessons for the Treatment of Urothelial Carcinoma

by Alexander Chehrazi-Raffle, Tanya B. Dorff, Sumanta K. Pal, Yung Lyou
Published 2021-02-01

Concomitant Radioembolization and Immune Checkpoint Inhibition in Metastatic Renal Cell Carcinoma

by Jacob J. Adashek, Meghan Salgia, Nazli Dizman, Jonathan Kessler, Sumanta K. Pal
Published 2018-05-01

Metastasis in renal cell carcinoma: Biology and implications for therapy

by Jun Gong, Manuel Caitano Maia, Nazli Dizman, Ameish Govindarajan, Sumanta K. Pal
Published 2016-10-01

Biomarkers of immunotherapy in urothelial and renal cell carcinoma: PD-L1, tumor mutational burden, and beyond

by Jason Zhu, Andrew J. Armstrong, Terence W. Friedlander, Won Kim, Sumanta K. Pal, Daniel J. George, Tian Zhang
Published 2018-01-01

Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors

by Chiara Casadei, Nazli Dizman, Giuseppe Schepisi, Maria Concetta Cursano, Umberto Basso, Daniele Santini, Sumanta K. Pal, Ugo De Giorgi
Published 2019-11-01

Mechanistic Investigation of the Androgen Receptor DNA-Binding Domain Inhibitor Pyrvinium

by Sumanta K. Pal, Ben Yi Tew, Minyoung Lim, Brittany Stankavich, Miaoling He, Miles Pufall, Weidong Hu, Yuan Chen, Jeremy O. Jones
Published 2019-02-01

Myeloid clusters are associated with a pro-metastatic environment and poor prognosis in smoking-related early stage non-small cell lung cancer.

by Wang Zhang, Sumanta K Pal, Xueli Liu, Chunmei Yang, Sachin Allahabadi, Shaira Bhanji, Robert A Figlin, Hua Yu, Karen L Reckamp
Published 2013-01-01

CKD-EPI and cockcroft-gault equations identify similar candidates for neoadjuvant chemotherapy in muscle-invasive bladder cancer.

by Sumanta K Pal, Nora Ruel, Sergio Villegas, Mark Chang, Kara DeWalt, Timothy G Wilson, Nicholas J Vogelzang, Bertram E Yuh
Published 2014-01-01

Reduced T-cell Numbers and Elevated Levels of Immunomodulatory Cytokines in Metastatic Prostate Cancer Patients De Novo Resistant to Abiraterone and/or Enzalutamide Therapy

by Sumanta K. Pal, Dayson Moreira, Haejung Won, Seok Woon White, Pryanka Duttagupta, Marc Lucia, Jeremy Jones, JoAnn Hsu, Marcin Kortylewski
Published 2019-04-01

Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma.

by David D Stenehjem, Andrew W Hahn, David M Gill, Daniel Albertson, Banumathy Gowrishankar, Joseph Merriman, Archana M Agarwal, Venkata Thodima, Erik B Harrington, Trang H Au, Benjamin L Maughan, Jane Houldsworth, Sumanta K Pal, Neeraj Agarwal
Published 2019-01-01

Complex Oncological Decision-Making Utilizing Fast-and-Frugal Trees in a Community Setting—Role of Academic and Hybrid Modeling

by Ravi Salgia, Isa Mambetsariev, Tingting Tan, Amanda Schwer, Daryl P. Pearlstein, Hazem Chehabi, Angel Baroz, Jeremy Fricke, Rebecca Pharaon, Hannah Romo, Thomas Waddington, Razmig Babikian, Linda Buck, Prakash Kulkarni, Mary Cianfrocca, Benjamin Djulbegovic, Sumanta K. Pal
Published 2020-06-01

Characterizing the relationships between tertiary and community cancer providers: Results from a survey of medical oncologists in Southern California

by Nicholas J. Salgia, Alexander Chehrazi‐Raffle, JoAnn Hsu, Zeynep Zengin, Sabrina Salgia, Neal S. Chawla, Luis Meza, Jasnoor Malhotra, Nazli Dizman, Ramya Muddasani, Nora Ruel, Mary Cianfrocca, Jun Gong, Sidharth Anand, Victor Chiu, James Yeh, Sumanta K. Pal
Published 2021-08-01